Coronary Artery Disease: Stent or
Surgery?
The results of an international study
comparing surgical bypass of multiple diseased coronary arteries with
minimally invasive angioplasty and coronary artery stenting is reported
in this week’s issue of the journal Lancet. The Stent or Surgery
(SoS) trial involved 53 hospitals throughout Europe and Canada, and
randomized 500 patients with multiple vessel coronary artery disease
to coronary artery bypass surgery (CABG), and 488 patients to percutaneous
transluminal coronary angioplasty with coronary artery stenting (PTCA-CAS).
CABG requires general anesthesia, surgical entry into the chest, and
the use of a heart bypass pump. PTCA-CAS, on the other hand, is performed
using local anesthesia and mild sedation, and involves the passage of
a special catheter through an artery in the thigh or upper arm. During
a CABG operation, the surgeon uses arteries in the chest or/and veins
in the legs to bypass the clogged segments of the coronary arteries
altogether. PTCA-CAS, on the other hand, employs a tiny expandable
balloon to expand the narrowed coronary arteries. An expandable metallic
stent is then left behind within the interior of the coronary arteries
to help maintain patency. This study was performed because earlier
studies of PTCA alone were associated with a high risk of recurrent
narrowing (stenosis) of coronary arteries following angioplasty.
All patients in this study were followed
for at least one year after undergoing either PTCA-CAS or CABG, with
more than half of the patients receiving follow-up for two or more years.
The researchers in this study found that 21% of the patients who underwent
PTCA-CAS required subsequent repeat procedures for restenosis of the
coronary arteries during this relatively brief follow-up period, while
the patients who received CABG required revascularization procedures
in 6% of cases. There was also a modest but significant difference
in the likelihood of death between the two patient groups. Among the
PTCA-CAS group, 5% of patients died during the study, while only 2%
of the CABG patients died.
The authors concluded that the addition
of coronary artery stenting to PTCA reduces the need for coronary artery
revascularization when compared to results obtained in previous studies
looking at PTCA alone. However, patients with multiple diseased coronary
arteries who undergo PTCA-CAS still appear to have a higher incidence
of requiring additional procedures to revascularize restenosed coronary
arteries than similar patients who are treated with CABG. The study
also identified a nearly three-fold increase in the risk of dying among
the PTCA-CAS patients when compared to the CABG patients. While nobody
looks forward to having their chest cracked open, their heart stopped,
and their coronary arteries bypassed, it appears that CABG remains a
superior treatment for patients with coronary artery disease involving
multiple vessels. As the technology for preventing restenosis following
coronary artery stenting continues to improve, I predict that the time
will come when PTCA-CAS will be as effective and as durable as CABG
(if not more so). At the same time, recent advances in minimally invasive
CABG on the beating heart, and without need for a heart bypass machine,
may continue to tip the scale in favor of CABG some time to come.
Best Way to Diagnose Appendicitis?
For centuries, surgeons have debated
the most accurate methods for making the clinical diagnosis of appendicitis.
Classical surgical texts describe the onset of appendicitis heralding
with vague periumbilical pain which then, at some later point, begins
to migrate or localize towards the right lower area of the abdomen.
The trouble with this scenario is two-fold. First of all, other disease
processes within the abdomen can cause nearly identical symptoms. For
example, swelling of the lymph nodes near the appendix after a viral
or bacterial infection is a notorious and common cause of “pseudoappendicitis.”
Secondly, the inflamed appendix, it would appear, doesn’t always read
the classical surgical texts regarding how it should behave. Patients
with bona fide appendicitis may present with many variations in the
location, timing, severity and quality of their pain, and may present
with other symptoms as well, making the diagnosis even more challenging.
Over the past 5 years, ultrasound and CT scans have been touted by some
experts as valuable aids in making—or excluding—the diagnosis of appendicitis.
Proponents of this expensive high tech approach cite the 10-15% incidence
of a normal appendix among male patients undergoing appendectomy when
clinical diagnosis alone was used. Women patients fare even worse when
the surgeon relies upon clinical considerations alone, with some studies
reporting a 40-50% incidence of an unremarkable appendix at the time
of surgery. On the other hand, since so many patients with suspected
appendicitis will ultimately prove to have some other condition (and,
often, a condition that does not require surgery), opponents of the
routine use of ultrasound or CT scanning claim that too many scarce
and expensive resources will be wasted on too many patients.
In this week’s journal Gastroenterology,
350 consecutive patients who presented to the emergency room with suspected
appendicitis participated in a research study that was designed to resolve
this ongoing controversy. All participating patients were categorized
according to the surgeons’ degree of clinical suspicion for a diagnosis
of appendicitis. All patients then underwent ultrasound evaluation
of their abdomen by a radiologist. As a surgeon, it pains me somewhat
to see that, according to this study, the radiologists fared quite a
bit better than their surgeon colleagues. Among the patients deemed
to be at low clinical risk of having appendicitis, 10% actually did
have the disease. Among the intermediate clinical probability group
of patients, 24% had a hot appendix. Within the group of patients that
the surgeons were most convinced of the diagnosis of appendicitis, only
65% of the patients actually had an inflamed appendix, while 18% had
some other identifiable cause for their belly pain, and 17% were never
found to have any abnormal conditions. Using ultrasound, the radiologists
were able to accurately make the diagnosis of appendicitis in 98% of
the patients who actually ended up having the disease, and incorrectly
made a diagnosis of appendicitis in only 2% of the patients who turned
out to have a normal appendix, for an overall diagnostic accuracy of
98%! These are pretty impressive numbers, and so, at least based upon
this study, the radiologists appear to have scored better in making
an accurate preoperative diagnosis when compared to the surgeons. I
will add two caveats, however. Firstly, performing a high quality ultrasound
scan is a subjective and complex process, and it really does take a
very skilled and experienced radiologist to reproduce the level of diagnostic
accuracy achieved in this study. Secondly, many hospitals not only
do not have radiologists with a lot of experience in making diagnosing
appendicitis with ultrasound, but finding such a rare creature late
at night in the hospital (i.e., when patients are rolling into the ER
because their abdominal pain is keeping them awake) is often an impossible
task. Still… I have to hand it to the radiologists participating in
this study, as their results are very impressive.
Antioxidants & the Risk of Stomach
Cancer
The proper role, if any, of dietary
antioxidant nutrients in the prevention of cancer is a hotly debated
subject. There are numerous studies showing either a reduction in the
incidence of cancer with an antioxidant-rich diet or no change in the
incidence of cancer. There is even a study that revealed an apparent
increase in the risk of lung cancer among smokers who also took
beta carotene supplements. Now, a new study in Gastroenterology
takes a look at the effects of dietary antioxidants on the risk of stomach
cancer. A total of 505 patients with newly diagnosed gastric cancer,
and 1,116 “control patients” without cancer, were enrolled into this
study. All participating patients were then carefully interviewed to
ascertain their dietary habits. The researchers then calculated the
antioxidant potential of each patient’s diet based upon the content
of specific vegetables and fruits that they commonly consumed. Briefly,
the study showed that patients with the highest intakes of antioxidant-rich
plant-based foods, overall, had a 35% lower incidence of stomach cancer
than patients with low levels of antioxidant-rich diets. When the incidence
of smoking among the two groups was accounted for, the inverse relationship
between dietary antioxidants and the risk of gastric cancer became even
more pronounced. Patients who had never smoked and who had the
highest levels of antioxidants in their diet had a 56% lower risk of
gastric cancer when compared to the other study patients.
While dietary survey studies are somewhat
subjective by their nature (as they rely upon the memory and honesty
of the test subjects), they are still powerful tools for assessing the
impact of dietary factors upon the development of diseases that may
be linked with eating and drinking habits. One can, therefore, infer
from this study that a diet rich in antioxidants may be associated with
a reduced risk of developing stomach cancer and that smoking,
particularly in the presence of low levels of antioxidants in the diet,
may increase the risk of gastric cancer.